Skip to main content Help with accessibility Skip to main navigation

DAPAGLIFLOZIN tablets (Forxiga®) for treating chronic kidney disease

CCG Approval Status:

Date Added: 15 - Oct - 2021
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of DAPAGLIFLOZIN tablets (Forxiga®) for treating chronic kidney disease.